These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 30153051)

  • 41. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
    Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
    Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Crossover comparison of timolol and latanoprost in chronic primary angle-closure glaucoma.
    Sihota R; Saxena R; Agarwal HC; Gulati V
    Arch Ophthalmol; 2004 Feb; 122(2):185-9. PubMed ID: 14769594
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Latanoprost versus timolol gel-forming solution once daily in primary open-angle glaucoma or ocular hypertension.
    Harasymowycz P; Hutnik CM; Nicolela M; Stewart WC
    Can J Ophthalmol; 2007 Feb; 42(1):75-81. PubMed ID: 17361245
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the nocturnal effects of once-daily timolol and latanoprost on intraocular pressure.
    Liu JH; Kripke DF; Weinreb RN
    Am J Ophthalmol; 2004 Sep; 138(3):389-95. PubMed ID: 15364220
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of timolol, latanoprost, and dorzolamide on circadian IOP in glaucoma or ocular hypertension.
    Orzalesi N; Rossetti L; Invernizzi T; Bottoli A; Autelitano A
    Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2566-73. PubMed ID: 10937568
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Latanoprost : an update of its use in glaucoma and ocular hypertension.
    Perry CM; McGavin JK; Culy CR; Ibbotson T
    Drugs Aging; 2003; 20(8):597-630. PubMed ID: 12795627
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Short-term effects of latanoprost on anterior chamber depth in patients with glaucoma or ocular hypertension.
    Gutiérrez-Ortiz C; Teus MA; Bolivar G
    Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):4856-9. PubMed ID: 17065498
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of topical hypotensive drugs on circadian IOP, blood pressure, and calculated diastolic ocular perfusion pressure in patients with glaucoma.
    Quaranta L; Gandolfo F; Turano R; Rovida F; Pizzolante T; Musig A; Gandolfo E
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2917-23. PubMed ID: 16799034
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evaluation of the rate of nonresponders to latanoprost therapy.
    Rossetti L; Gandolfi S; Traverso C; Montanari P; Uva M; Manni G; Carassa R; Mastropasqua L; Quaranta L; Marchini G; Ratiglia R; Orzalesi N
    J Glaucoma; 2006 Jun; 15(3):238-43. PubMed ID: 16778647
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Association between genetic polymorphisms of the prostaglandin F2alpha receptor gene and response to latanoprost.
    Sakurai M; Higashide T; Takahashi M; Sugiyama K
    Ophthalmology; 2007 Jun; 114(6):1039-45. PubMed ID: 17467803
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
    Ishibashi S; Hirose N; Tawara A; Kubota T
    J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A study of replacement of timolol-pilocarpine with latanoprost in pseudoexfoliation glaucoma.
    Bojić L; Mandić Z; Novak-Laus K; Sonicki Z; Karelović D
    Coll Antropol; 2003 Dec; 27(2):729-34. PubMed ID: 14746165
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ultrasound biomicroscopic study of ciliary body thickness after topical application of pharmacologic agents.
    Mishima HK; Shoge K; Takamatsu M; Kiuchi Y; Tanaka J
    Am J Ophthalmol; 1996 Mar; 121(3):319-21. PubMed ID: 8597277
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A comparative analysis of the effects of the fixed combination of timolol and dorzolamide versus latanoprost plus timolol on ocular hemodynamics and visual function in patients with primary open-angle glaucoma.
    Siesky B; Harris A; Sines D; Rechtman E; Malinovsky VE; McCranor L; Yung CW; Zalish M
    J Ocul Pharmacol Ther; 2006 Oct; 22(5):353-61. PubMed ID: 17076630
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A comparison of the effects of dorzolamide/timolol fixed combination versus latanoprost on intraocular pressure and pulsatile ocular blood flow in primary open-angle glaucoma patients.
    Janulevicienë I; Harris A; Kagemann L; Siesky B; McCranor L
    Acta Ophthalmol Scand; 2004 Dec; 82(6):730-7. PubMed ID: 15606472
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Changes in optic nerve head blood flow induced by the combined therapy of latanoprost and beta blockers.
    Sugiyama T; Kojima S; Ishida O; Ikeda T
    Acta Ophthalmol; 2009 Nov; 87(7):797-800. PubMed ID: 19053956
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Interaction with therapeutic soft contact lenses affects the intraocular efficacy of tropicamide and latanoprost in dogs.
    Hatzav M; Bdolah-Abram T; Ofri R
    J Vet Pharmacol Ther; 2016 Apr; 39(2):138-43. PubMed ID: 26411631
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of 1% prednisolone acetate on pupil diameter and intraocular pressure in healthy dogs treated with 0.005% latanoprost.
    Kahane N; Bdolah-Abram T; Raskansky H; Ofri R
    Vet Ophthalmol; 2016 Nov; 19(6):473-479. PubMed ID: 26621425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A 6-week, double-masked, parallel-group study of the efficacy and safety of travoprost 0.004% compared with latanoprost 0:005%/timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
    Franks WA; Renard JP; Cunliffe IA; Rojanapongpun P
    Clin Ther; 2006 Mar; 28(3):332-9. PubMed ID: 16750448
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.